5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer
- PMID: 356983
5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer
Abstract
Eighteen previously untreated patients with advanced nonresectable adenocarcinoma of the stomach were treated with a four-drug regimen consisting of 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C. Objective responses occurred in only two patients (11%); the majority of patients had stable disease for greater than or equal to 8 weeks (61%). The median survival of 27 weeks was similar to that reported in other combination chemotherapy trials. Numerous staging and restaging procedures and strict response criteria were utilized and each was evaluated for its effectiveness in following responses. None of these parameters was useful for evaluating response of intra-abdominal tumor. We conclude that this four-drug combination is no better than previously described two-drug regimens.
Similar articles
-
Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1863-9. Cancer Treat Rep. 1979. PMID: 393381 Clinical Trial.
-
Phase II-III chemotherapy studies in advanced gastric cancer. The Gastrointestinal Tumor Study Group.Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1871-6. Cancer Treat Rep. 1979. PMID: 393382 Clinical Trial.
-
Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.Cancer Treat Rep. 1982 Aug;66(8):1613-7. Cancer Treat Rep. 1982. PMID: 7105051
-
Chemotherapy in alimentary tract malignomas.Hepatogastroenterology. 1981 Oct;28(5):276-83. Hepatogastroenterology. 1981. PMID: 6212524 Review. No abstract available.
-
Chemotherapy of advanced gastric cancer: present status, future prospects.Semin Oncol. 1988 Jun;15(3 Suppl 4):42-9. Semin Oncol. 1988. PMID: 3293218 Review.
Cited by
-
Combination chemotherapy enhances survival of patients with unresectable gastric cancer.Jpn J Surg. 1983 Sep;13(5):409-14. doi: 10.1007/BF02469727. Jpn J Surg. 1983. PMID: 6668775
-
Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach.Jpn J Surg. 1981;11(4):291-6. doi: 10.1007/BF02468770. Jpn J Surg. 1981. PMID: 6793759
-
5-fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer.Cancer Chemother Pharmacol. 1984;12(3):194-7. doi: 10.1007/BF00256545. Cancer Chemother Pharmacol. 1984. PMID: 6368030 Clinical Trial.
-
Update in cancer chemotherapy: gastrointestinal cancer, cancer of the stomach and carcinoid tumors.J Natl Med Assoc. 1986 Jul;78(7):623-32. J Natl Med Assoc. 1986. PMID: 3528508 Free PMC article. Review.